Sitting on a Cash Pile 12.0? BioTech Favored Over Legacy Pharma

By Paul Ebeling on March 2, 2021   2021, Investments, Paul Ebeling, Todays Trade Ideas  

#cash #bullish #buy $BCRX BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) brokout on 10 November at 4.08 and confirmed on 11 March at 11.98. Thus garnering an LTN Cash Pile Buy rating with a 1yr price target at 16+/share The stock is currently trading at 11.98 within its 52 wk trading range of 1.58 – 12.90 The consensus […]